Abstracts and Articles

MASH

The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.

1 11/01/2025

A Phase 2a Trial of Myeloperoxidase Inhibitor Mitiperstat in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis.

Armisen Javier (J);Flor Armando (A);Eriksson John (J);Nelander Karin (K);Bhattacharya Chandrali S (CS);Sunnåker Mikael (M);Carter Debra (D);Trebski Monika (M);Gårdmark Emma (E);Aurell Malin (M);Whatling Carl (C);Challis Benjamin (B);Vespasiani-Gentilucci Umberto (U); ()

2 11/01/2025

Physical Activity by Accelerometer Inversely Associated With Liver Fibrosis; Cross-Sectional Analysis of a Longitudinal Cohort.

Haff Madeleine G (MG);Murabito Joanne M (JM);Vasan Ramachandran S (RS);Spartano Nicole L (NL);Liu Ching-Ti (CT);Zhang Xiaoyu (X);Benjamin Emelia J (EJ);Lewis Gregory D (GD);Long Michelle T (MT)

3 10/25/2025

Enhancing MAFLD Care: Efficacy of a Multidisciplinary Community Intervention on Self-Management and Hepatic Outcomes.

Cai Huan-Jing (HJ);Liang Hai-Lun (HL);Shi Lei-Yu (LY);Rong Yi-Hui (YH);Li Jing (J);Zhang Yan (Y);Ma Rui-Fang (RF)

4 10/24/2025

Quantitative Approaches to Accelerate MASH Drug Discovery and Development.

Abouelhassan Yasmeen (Y);Tallapaka Shailendra (S);Mehrani Ramin (R);Siler Scott Q (SQ);Qin Li (L);Wang Zeyuan (Z);Trujillo Maria E (ME)

5 10/24/2025

Tirzepatide-induced weight loss and obstructive sleep apnea improvement in an adult with type 2 diabetes: A case report.

Funamizu Noriko (N);Funamizu Naotake (N);Hirose Tsunemichi (T)

6 10/24/2025

"Hybrid exercise training improves liver steatosis and inflammation in a randomized trial of sedentary, obese women with non-alcoholic fatty liver disease".

Mohammadzadeh Niloofar Zareie (NZ);Rezaeipour Mohammadreza (M)

7 10/23/2025

Refining the Baveno VII criteria for clinically significant portal hypertension: an individual-patient data meta-analysis.

Bañares Juan (J);Pons Mònica (M);Reiberger Thomas (T);Mandorfer Mattias (M);Jachs Mathias (M);Semmler Georg (G);Colecchia Antonio (A);Colecchia Luigi (L);Dajti Elton (E);Bureau Christophe (C);Larrue Hélène (H);Grgurević Ivica (I);Kujundžić Petra Dinjar (PD);Fortea Jose Ignacio (JI);Puente Angela (A);Berzigotti Annalisa (A);Tsochatzis Emmanuel (E);Bosch Jaime (J);Abraldes Juan G (JG);Genesca Joan (J); ()

8 10/23/2025

Evaluation of a new TyG indicator, TyHGB, in predicting non-alcoholic fatty liver disease: evidence from two independent populations.

Zhao Enfa (E);Wang Ruimeng (R);Chen Yiqing (Y);Xie Hang (H);Gao Yuan (Y);Dong Bingtian (B);Zhang Chaoxue (C)

9 10/23/2025

Effects of Resmetirom on Metabolic-Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon-Like Peptide-1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO-NASH Trial.

Noureddin Mazen (M);Rinella Mary (M);Taub Rebecca (R);Labriola Dominic (D);Camacho Raul C (RC);Alkhouri Naim (N);Loomba Rohit (R);Bansal Meena B (MB)

10 10/23/2025

The Effect of Time-Restricted Eating on Metabolic Risk Factors for Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease in Overweight and Obese Adults: A Systematic Review and Meta-Analysis.

Park Jooho (J);Kim Min Soo (MS);Boo Yoo-Kyung (YK)

11 10/23/2025

Exercise Guidelines for Enhancing Mobility and Stability in Individuals with Severe Obesity.

Lee Hae Sung (HS);Suk Min-Hwa (MH);Jang Hee Seung (HS);Kim Jong-Hee (JH)

12 10/22/2025

GIP/GLP-1RA as adjunctive to automated insulin delivery in adults with Type 1 diabetes (the AID-JUNCT trial): Study protocol for a prospective, randomized, clinical trial.

Fragozo-Ramos Maria Carolina (MC);Schenker Gabriela (G);Hepprich Matthias (M);Gallo-Villegas Jaime (J);Züger Thomas (T);Garcia-Tirado Jose (J)

13 10/21/2025

Research Communication: Changing Aetiology of Chronic Liver Diseases in East Asia Pacific and HCC Surveillance in Non-Cirrhotic Patients.

Liu Ming (M);Liu Chuan (C);Mok Tsz Ngai (TN);Qi Xiaolong (X);Ming Wai-Kit (WK)

14 10/21/2025

Routine endoscopy prior to bariatric surgery: evidence-based necessity or institutional tradition?

Doğan Serhat (S);Kanat Burhan Hakan (BH)

15 10/21/2025

Incidence and predictors of mortality among persons with rifampicin-resistant tuberculosis and HIV in Mozambique.

Nacarapa Edy (E);Jose Benedita (B);Munyangaju Isabelle (I);Osório Dulce (D);Ramos-Rincon Jose-Manuel (JM)

16 10/21/2025

The impact of food insecurity on chronic liver disease: A systematic review of the literature.

Elias Laila M (LM);Agins Jordy E (JE);Goldberg David S (DS);Bittermann Therese (T);Byhoff Elena (E)

17 10/21/2025

Liver Fat Quantification and Steatosis Grading in Fatty Liver Disease by Magnetic Resonance Imaging: Systematic Review and Meta-Analysis.

Al-Huneidi Layan I (LI);Zhao Feng (F);Maas Romy (R);Ermans Sven J E (SJE);Runge Jurgen (J);Chen Xiangbai (X);Ji Jim X (JX);Alic Lejla (L)

18 10/21/2025

Mortality and Cardiovascular Outcomes in Patients with MAFLD Compared with Patients with MASLD: A Systematic Review and Meta-Analysis.

Yang Jiwon (J);Kim Ye Rim (YR);Na Seong Kyun (SK);Kim Seonok (S);An Jihyun (J);Shim Ju Hyun (JH)